Latest filing published 19 Feb 2026 for Neumora Therapeutics, Inc., €18k.
Filing timeline
BuySaleInsider track record
Joshua Pinto: trading record in brief
Joshua Pinto discloses dealings in 2 companies, chiefly Neumora Therapeutics, Inc. and Metsera, Inc. In total, 11 filings cover trades dated from 14 February 2024 to 17 February 2026.
Sales make up the whole of the open-market record (6 sales, €1.1M). The rest of the record consists of 1 share grant. Since January 2026: no purchases and 1 sale on the market.
The latest filing, published on 19 February 2026, reports an open-market sale of €18k in Neumora Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Joshua Pinto
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,967 shares@ US$3.5353.6% of flowCommon StockSEC:0001610717-26-000053:0
- 2,688 sharesCommon StockSEC:0001193125-25-280799:0
- 13,202 shares0Common StockSEC:0001610717-25-000128:0
- 8,048 shares@ US$1.67462.6% of flowCommon StockSEC:0001610717-25-000027:0
- 15,693 shares@ US$11.39432.7% of flowCommon StockSEC:0001610717-24-000457:0
- 28,496 shares@ US$11.632161.0% of flowCommon StockSEC:0001610717-24-000456:0
- 238,965 shares0Common StockSEC:0001610717-24-000380:0
- 85,000 shares0Common StockSEC:0001610717-24-000069:0
8 of 8 declarations
